Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics (CRDL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cardiol Therapeutics 2265 UPPER MIDDLE ROAD EAST SUITE 602 OAKVILLE A6 L6H 0G5 CAN

P: 289-910-0850

Description:

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

Key Statistics

Overview:

Market Capitalization, $K 42,550
Enterprise Value, $K -24,390
Shares Outstanding, K 64,043
Annual Sales, $ 60 K
Annual Net Income, $ -25,240 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,972 K
60-Month Beta -0.19
% of Insider Shareholders 5.25%
% of Institutional Shareholders 7.46%
Float, K 60,681
% Float 94.75%
Short Volume Ratio 0.43

Growth:

1-Year Return -61.74%
3-Year Return -78.57%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 11/10/22
Next Earnings Date 03/22/23
Earnings Per Share ttm -0.29
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 44.44%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CRDL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.32%
Return-on-Assets % -38.18%
Profit Margin % -42,066.67
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.00
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar